December 30, 2025 • 16 mins
The conventional story of type 2 diabetes—lifelong, progressive, and medication-dependent—misses the deeper biology driving the disease. In this episode of The Health Pulse, we unpack selective insulin resistance across the liver, adipose tissue, and skeletal muscle, and explain how restoring insulin sensitivity systemwide can lead to true remission, not just better numbers.
We explore the liver’s paradoxical behavior—continuing to produce glucose while aggressively storing fat—and how fatty liver, elevated triglycerides, and visceral fat spillover lock patients into high insulin and high glucose states. From there, we turn to skeletal muscle, the body’s largest glucose sink, and show how targeted movement and nutrition dramatically improve post-meal glucose clearance.
You’ll learn the four pillars of remission: restoring liver sensitivity, calming adipose tissue dysfunction, reactivating muscle glucose uptake, and lowering daily insulin demand so the pancreas can recover. We discuss carbohydrate reduction as a strategic metabolic lever, clarify metformin’s role as supportive—not a failure—and explain why escalating insulin doses without addressing diet and stress can actually worsen resistance.
Finally, we highlight smarter lab markers beyond A1C—fasting insulin, triglycerides, TG:HDL ratio, and liver enzymes—to track real metabolic progress. If you’re looking for a sustainable, physiology-first approach to reversing type 2 diabetes, this episode provides a clear, actionable roadmap.
📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.
📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com
💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.
Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Nicolette (00:00):
Welcome to the Health Post, your go-to source for
quick, actionable insights onhealth, wellness, and
diagnostics.
Whether you're looking tooptimize your well-being or stay
informed about the latestin-medical testing, we've got
you covered.
Join us as we break down keyhealth topics in just minutes.
Let's dive in.
Mark (00:23):
Welcome back to the deep dive.
Rachel (00:25):
Uh.
Mark (00:26):
So if you or you know someone close to you has
received a diagnosis of type 2diabetes, you've probably heard
the traditional, uh, rather grimscript.
Rachel (00:34):
Right, that it's permanent.
Mark (00:36):
Exactly.
It's progressive, and you'rejust gonna need more and more
medication as time goes on.
But if that sounds like a finalverdict, our sources are
suggesting you really need tohear this.
We're finding that theconventional wisdom is, well,
it's deeply flawed.
Research, especially over thelast couple of decades, has
shown a completely differenttruth.
Rachel (00:55):
Aaron Powell And that is that T2D, especially when you
address it early, is oftenreversible.
It can be put into a state wecall remission.
Mark (01:03):
And that's a really crucial word.
Rachel (01:05):
It is.
And we need to be clearremission is not a cure, the
genetic side of things, thatremains, but it means the body
has achieved a real sustainablereset.
Mark (01:14):
Aaron Powell So your blood sugar has normalized.
Rachel (01:16):
It's normalized without the help of glucose-lowering
medication for, you know, a goodamount of time.
But to understand how to getthere, we have to stop thinking
about T2D as just a high bloodsugar problem.
Mark (01:27):
Right.
That's just the symptom.
Rachel (01:29):
It is.
So our mission today is to divedeep into the body's uh
metabolic choreography, thisreally complex, often chaotic
dance between the liver, muscle,and fat tissue to understand
the real drivers.
Mark (01:41):
Aaron Powell Okay, let's unpack this.
We're gonna focus first on whatTTD really is, which is uh a
crisis of selectivecommunication.
Then we'll detail the specificphysiological changes that have
to happen for that remission tooccur.
And finally, we're gonna giveyou the key lab markers that
paint a far, far better pictureof your progress than just, you
know, checking your glucosealone.
(02:03):
So let's start by reframingthis whole disease.
We like to think of insulin asthe body's master metabolic
hormone.
It's like a traffic cop, right?
Rachel (02:10):
Right.
It's deciding where energygoes.
Does it get burned or does itget stored?
Mark (02:14):
Exactly.
And the problem in T2D isn'tjust high glucose, that's the
result.
The core issue is that yourtissues, your liver, your fat,
your muscles, they just stopresponding to that traffic cop
in a coordinated way.
Rachel (02:26):
And what the research really clarifies is that this
resistance, it's not some simpleon or off switch.
Mark (02:31):
So it's not all or nothing.
Rachel (02:33):
Not at all.
If all insulin action juststopped, you'd be in absolute
metabolic distress immediately.
Instead, T2D is characterizedby what we call uh partial or
selective insulin resistance.
Meaning that when insulinissues a command, some cells
hear it loud and clear, somehear it faintly, and well, some
seem to ignore one command whilestill following another
(02:55):
perfectly.
Mark (02:55):
And that unevenness.
Rachel (02:56):
Yeah.
Mark (02:57):
That's the root of the chaos.
Rachel (02:58):
That's it.
Mark (02:59):
So this brings us to what you call the central paradox.
And this happens in the liver.
So normally you eat insulinspikes and it sends two
immediate, really criticalmessages to your liver.
What are they?
Rachel (03:11):
Okay.
So first, insulin tells theliver stop producing new
glucose.
That process is called uhgluconeogenesis.
Mark (03:18):
Making new sugar.
Rachel (03:19):
Literally.
And second, insulin tells theliver, okay, we have extra fuel,
store it safely, and you know,turn some of that extra energy
into fat if you need to.
That's lipogenesis.
Mark (03:29):
Aaron Powell So in this state of selective resistance,
what happens to those twocommands?
Rachel (03:33):
This is where that communication breakdown becomes
so destructive.
The liver, it basically goesdeaf to that first vital
message.
Mark (03:41):
The one to stop making glucose.
Rachel (03:42):
That signal is lost.
So even when your blood sugaris already high from a meal, the
liver just keeps churning outmore glucose.
Mark (03:50):
It's like an overflowing sink and the tap won't turn off.
Rachel (03:52):
Aaron Powell It's a perfect analogy.
And that's precisely why we seethose elevated fasting glucose
levels.
Mark (03:57):
Okay.
Meanwhile, what happens to thatsecond command, the one to
store fuel and make fat?
Rachel (04:02):
The material really emphasizes this.
That signaling pathway oftenremains robustly intact.
Oh wow.
So now the liver is in thisimpossible situation where it is
simultaneously producing waytoo much glucose.
And too much fat at the sametime.
This dual overproduction isdeeply damaging.
It leads to fat accumulatingright in the liver itself, what
(04:23):
we call fatty liver disease, orNAFLD, which then just
dramatically worsens overallinsulin resistance.
Mark (04:29):
It's a vicious cycle.
Rachel (04:30):
It's the signature cycle of metabolic syndrome and T2D.
Mark (04:34):
Okay, so let's shift gears.
We tend to think of fat tissueadipose tissue as, I don't know,
just a passive sac where westore energy.
Rachel (04:41):
Right.
Mark (04:42):
But our deep dive suggests that fat is an incredibly
active metabolic organ.
It's not just where resistanceis stored, it's one of the main
drivers making the problem worseeverywhere else.
Rachel (04:53):
Absolutely.
Think of your fat tissue,especially the uh visceral or
abdominal fat as a reservoirthat's under pressure.
When those fat cells becomedysfunctional because of insulin
resistance, they stopregulating storage properly.
Mark (05:06):
Okay.
Rachel (05:07):
So instead of keeping fatty acids locked away, they
start releasing excessiveamounts of free fatty acids or F
FFA into the bloodstream.
We call this fatty acidspillover.
Mark (05:17):
And why is that spillover so bad?
What do these free fatty acidsdo?
Rachel (05:20):
They're essentially metabolic toxins once they're
out in the open like that.
They travel directly to otherorgans like the liver and the
muscle, and they activelyinterfere with insulin's ability
to signal properly.
Mark (05:32):
So they're spreading the resistance.
Rachel (05:33):
Exactly.
They promote furtherresistance, making glucose
control dramatically worse.
The fat tissue is no longerjust sitting there, it's
aggressively undermining thebody's entire fuel handling
system.
Mark (05:44):
Creating a powerful, reinforcing feedback loop.
Rachel (05:48):
A loop that locks the body into a state of disease.
Mark (05:51):
So the body is fighting this war on two fronts.
The liver is overproducingglucose, and now dysfunctional
fat is flooding the system withthese resistance-inducing fatty
acids.
That brings us to the muscles.
What's their role?
Rachel (06:05):
Muscle tissue is the body's largest potential glucose
consumer.
It's a huge sink for glucose.
Mark (06:10):
So after a meal, it should be soaking it all up.
Rachel (06:12):
It should be sponging up a huge amount of that glucose
to replenish its energy stores.
But in T2D, the muscle becomes,well, lazy.
It's less responsive toinsulin.
Which means Which means glucoseclearance is slow, and that
prolongs that post-meal spike ofglucose in your bloodstream.
Mark (06:29):
And when the muscle isn't clearing the glucose and the
liver keeps making it, who picksup the slack?
We often assume T2D means thepancreas has just failed, but
that's not what happens earlyon, is it?
Rachel (06:39):
No, it's actually the opposite.
Early T2D is usually not aboutinsulin deficiency.
The pancreas, it compensatesfor all this resistance by
working overtime.
It pumps out vastly moreinsulin, sometimes four or five
times the normal amount.
Right.
The core problem is that thebody just requires too much
insulin to function because thetissues are so resistant.
Mark (07:01):
So the pancreas is being asked to run a marathon every
single day.
Rachel (07:04):
Every single day.
And it's this constant highdemand, this overwork that puts
chronic crippling stress on theinsulin-producing beta cells.
Mark (07:12):
Not a sudden thing.
Rachel (07:13):
It's not a sudden failure.
It's a gradual functionalexhaustion over many, many years
that eventually leads to thedecline of those crucial cells.
Mark (07:21):
Okay, so if T2D is this deep metabolic problem, this
chaotic interaction, thenachieving remission has to
require deep physiologicalchanges.
Rachel (07:30):
Mm-hmm.
Mark (07:30):
Better blood glucose is just the consequence of these
deeper changes, not the maingoal itself.
And the material points to fourthings that have to improve
together.
Rachel (07:39):
That's right.
And the first two points goright back to calming the chaos
we just talked about.
Point one is restoring liversensitivity.
The liver has to regain itsability to listen to insulin's
signal to, you know, cut back onglucose output.
Mark (07:53):
Aaron Powell And that's tied to liver fat.
Rachel (07:55):
It is directly linked to reductions in liver fat.
And the research suggests thatlosing liver fat is often more
important for remission thanoverall weight loss alone.
You reduce liver fat, youquickly see lower fasting
glucose.
Mark (08:07):
And then we had to deal with that fuel spillover.
So point two is restoringadipose tissue sensitivity.
Trevor Burrus, Jr.
Rachel (08:13):
That's critical.
The fat cells need to becomesensitive again so that insulin
can effectively suppress thatunnecessary fat breakdown, what
we call the anti-lipolyticsignal.
Mark (08:22):
And when that happens.
Rachel (08:23):
The dangerous fatty acid spillover to the liver and
muscle slows right down, whichallows those other organs to
finally function better.
Mark (08:30):
Aaron Powell And then moving on, we had to get our
main fuel consumer back in thegame.
Point three is muscle recovery.
Rachel (08:35):
Yep.
We need that muscle tissue tobecome sensitive again to clear
glucose efficiently after mealsand stabilize those postmeal
levels.
Mark (08:43):
Aaron Powell Physical activity helps with that,
obviously.
Rachel (08:45):
Aaron Powell Enormously.
Mark (08:46):
Yeah.
Rachel (08:46):
But the sources are clear that dietary factors that
reduce the glucose overload inthe first place are just as
important.
Mark (08:53):
Which leads us perfectly to the ultimate goal.
Point four, lowering insulindemand.
Rachel (08:58):
That's the end game.
The objective is todramatically reduce the sheer
quantity of insulin the bodyneeds just to get through the
day.
Mark (09:05):
And when that demand falls.
Rachel (09:07):
That exhausted pancreas finally gets a chance to rest
and recover, which helpspreserve its function for the
long term.
Remiss is really that momentwhen the whole system is working
efficiently again at a muchlower level of stress.
Mark (09:20):
Right.
Let's get practical.
Let's talk strategies.
If the main goal is loweringinsulin demand and easing all
this metabolic pressure, thereason why reducing dietary
carbs is so central becomesreally clear.
Rachel (09:32):
It does.
Mark (09:33):
It's not just about avoiding sugar.
It's a whole metabolicrestructuring.
Rachel (09:37):
Think about the resistance system as a factory
that's already running at maxcapacity.
Carbohydrates are the mainnutrient that raises blood
glucose and therefore triggersthat immediate, urgent release
of insulin.
Mark (09:49):
So if you're already resistant.
Rachel (09:50):
A high carbohydrate intake means you're just
constantly forcing your pancreasto pump out more and more
insulin just to keep your bloodsugar from going haywire.
Mark (09:58):
So how exactly does reducing that glucose input help
the pancreas?
Is it just less work or isthere more to it?
Rachel (10:05):
It's both.
Less glucose coming in meansblood sugar rises less after
meals, so you need less insulinoverall.
This stabilization reduces thatchronic high level of insulin,
which is anti-inflammatory, andlets the pancreas rest.
Mark (10:20):
And the liver?
Rachel (10:21):
Oh, the liver is highly sensitive to the amount of
glucose coming in.
Lower card input decreases theliver's tendency to overproduce
glucose, it helps it shed thatliver fat faster, and it
improves the liver's overallresponse to insulin.
It tackles that paradox headon.
Mark (10:36):
Now, medication, like metformin, often comes into the
picture early, and the materialsuggests we should see it not as
a defeat, but as a a temporarytool.
Rachel (10:46):
The support tool.
That's the key mindset shift.
Metformin primarily works onthe liver to reduce that
excessive glucose production.
It basically puts a speed limiton that broken tap.
Mark (10:55):
So it lowers the burden.
Rachel (10:56):
Exactly.
It lowers the overall metabolicburden, it gives the system a
critical break, and it allowsthe recovery process from diet
and lifestyle to just happenfaster.
Mark (11:05):
The sources do make a strong point about treatment,
though.
If the core problem isresistance, we have to question
the traditional approach of justadding more and more insulin.
Rachel (11:15):
That is a crucial area for you to consider.
T2D is resistance.
And while insulin is, ofcourse, necessary for type 1
diabetes, using ever-escalatingdoses of insulin in a T2D
patient who hasn't fullycontrolled their glucose load
can be counterproductive.
Mark (11:33):
How so?
Rachel (11:34):
Well, high insulin levels can sometimes reinforce
the resistance, creating areally toxic feedback loop.
The need for more and moreinjected insulin should always
be a signal that something isfundamentally unaddressed.
Trevor Burrus, Jr.
Mark (11:45):
Either the diet or something else.
Trevor Burrus, Jr.
Rachel (11:47):
Or perhaps more likely unaddressed stressors.
Mark (11:50):
Aaron Powell And if the dietary input is controlled but
glucose is still stubbornlyhigh, that's when we have to
look for those underappreciatedphysiologic stressors that are
actively sabotaging insulinaction.
What are some of those?
Rachel (12:01):
Aaron Powell This is where the deeper investigation
begins.
The most common is excesscortisol, often driven by
chronic emotional stress, pain,or just poor sleep quality.
Mark (12:10):
And cortisol raises blood sugar.
Rachel (12:12):
It's a powerful counter-regulatory hormone.
When it's chronically high, itconstantly opposes insulin.
We also have to look at loss ofmuscle mass sarcopenia.
Remember, muscle is yourbiggest glucose sponge.
Right.
If you lose it, you have fewerplaces for the glucose to go,
which makes managementexponentially harder.
And finally, you look forthings like systemic
(12:33):
inflammation or hormonalimbalances.
If glucose control is tough,you have to look beyond the
plate and consider the totalphysiologic burden on your body.
Mark (12:41):
This brings us to the final and maybe most actionable
piece for you (12:44):
tracking success.
Blood glucose checks and HBA1C,they give you an incomplete
picture.
Rachel (12:51):
Very incomplete.
Mark (12:51):
They tell you what happened, but not why it
happened or where the breakdownis.
You need better information.
Rachel (12:56):
You need to measure insulin demand.
A single lab measurement offasting insulin taken alongside
your glucose reading gives youvital context.
And the distinction here reallymatters for your action plan.
Mark (13:06):
Okay, let's break down the two main scenarios.
Rachel (13:09):
Scenario one you have high fasting insulin and high
glucose.
That screams severe resistance.
Your pancreas is still tryingto keep up.
It's working hard, but it'sfailing because the demand is
overwhelming.
So the focus there has to beruthlessly on reducing that
glucose load and maximizingtissue sensitivity.
Mark (13:30):
Okay.
And scenario two, what if thepancreas has started to get
tired?
Rachel (13:35):
Well, if you have normal or even low fasting insulin and
high glucose, that raises areal concern for significant
beta cell dysfunction.
Or maybe a powerful acuteinterfering factor like severe
stress or an illness.
Mark (13:49):
And that distinction changes the whole plan.
Rachel (13:51):
Completely.
It guides the clinician onwhether to focus on resting the
pancreas or digging deeper intohormonal interference.
Mark (13:57):
So fasting insulin tells us the status of the pancreas.
What about tracking that lividchaos, the liver fat and the
overflow?
Rachel (14:03):
For that, you should always track your triglycerides
and the triglyceride to HDLratio.
Mark (14:08):
Okay.
Rachel (14:08):
Research shows these markers correlate powerfully
with that hepatic insulinresistance and the lipid
spillover from dysfunctionalfat.
Mark (14:14):
So high triglycerides, low HDL, that's a bad sign.
Rachel (14:19):
It's a strong indicator of metabolic chaos.
But these are often the veryfirst things that improve, often
before your glucose stabilizes,which shows you that the deep
changes are working.
We also look at basic liverenzymes, ALT and AST.
Even when they're in the normalrange, a slight elevation can
still suggest some fatty liverinvolvement.
Mark (14:40):
So these tests let you pinpoint which lever is still
stuck.
Is it the liver?
Is it the fat tissue?
Or is it some hidden hormonalstressor?
Rachel (14:49):
Aaron Powell Precisely.
It stops you from justescalating therapy blindly
because the HBA1C is high.
Mark (14:54):
So HBA1C is more of a lagging indicator.
Rachel (14:57):
It's a trajectory marker.
It tells you where you've beenfor the last three months.
But these other metabolicmarkers, fasting insulin,
triglycerides, the ratio, theytell you where you are going and
critically why certainstrategies are or aren't
working.
Mark (15:08):
Aaron Powell So let's bring it all together.
The core takeaway from thisdeep dive is that T2D is not a
sentence of permanent metabolicdecline.
Rachel (15:15):
Not at all.
Mark (15:15):
It's highly modifiable, especially in the early stages.
And remission is achieved byrestoring that metabolic
balance.
Rachel (15:21):
It's about reducing glucose input, dramatically
improving sensitivity acrossyour liver, muscle, and fat
tissues, and successfullylowering the demand placed on
your pancreas.
Mark (15:32):
A total system reset.
Rachel (15:33):
Exactly.
And here is the final thoughtfor you to carry forward.
If you are doing everythingright, you have sincerely
addressed your diet, you'reconsistent, and yet your blood
glucose is proving stubbornlyhard to control, what
unaddressed hormonal orinflammatory stressor could be
powerfully opposing insulinaction right now.
Mark (15:50):
Is it sleep?
Is it stress?
Rachel (15:53):
Is it chronic cortisol?
Identifying that hidden force,that's where the deeper
investigation and your bestchance at lasting remission
truly begins.
Mark (16:01):
Thank you for joining us for this deep dive into decoding
the metabolic paradox.
Nicolette (16:05):
We hope this knowledge empowers you to ask
better questions and achievebetter
results.quicklabmobile.com.
(16:27):
Stay informed, stay healthy,and we'll catch you in the next
episode.
Welcome to the Health Post, your go-to source for
quick, actionable insights onhealth, wellness, and
diagnostics.
Whether you're looking tooptimize your well-being or stay
informed about the latestin-medical testing, we've got
you covered.
Join us as we break down keyhealth topics in just minutes.
Let's dive in.
Mark (00:23):
Welcome back to the deep dive.
Rachel (00:25):
Uh.
Mark (00:26):
So if you or you know someone close to you has
received a diagnosis of type 2diabetes, you've probably heard
the traditional, uh, rather grimscript.
Rachel (00:34):
Right, that it's permanent.
Mark (00:36):
Exactly.
It's progressive, and you'rejust gonna need more and more
medication as time goes on.
But if that sounds like a finalverdict, our sources are
suggesting you really need tohear this.
We're finding that theconventional wisdom is, well,
it's deeply flawed.
Research, especially over thelast couple of decades, has
shown a completely differenttruth.
Rachel (00:55):
Aaron Powell And that is that T2D, especially when you
address it early, is oftenreversible.
It can be put into a state wecall remission.
Mark (01:03):
And that's a really crucial word.
Rachel (01:05):
It is.
And we need to be clearremission is not a cure, the
genetic side of things, thatremains, but it means the body
has achieved a real sustainablereset.
Mark (01:14):
Aaron Powell So your blood sugar has normalized.
Rachel (01:16):
It's normalized without the help of glucose-lowering
medication for, you know, a goodamount of time.
But to understand how to getthere, we have to stop thinking
about T2D as just a high bloodsugar problem.
Mark (01:27):
Right.
That's just the symptom.
Rachel (01:29):
It is.
So our mission today is to divedeep into the body's uh
metabolic choreography, thisreally complex, often chaotic
dance between the liver, muscle,and fat tissue to understand
the real drivers.
Mark (01:41):
Aaron Powell Okay, let's unpack this.
We're gonna focus first on whatTTD really is, which is uh a
crisis of selectivecommunication.
Then we'll detail the specificphysiological changes that have
to happen for that remission tooccur.
And finally, we're gonna giveyou the key lab markers that
paint a far, far better pictureof your progress than just, you
know, checking your glucosealone.
(02:03):
So let's start by reframingthis whole disease.
We like to think of insulin asthe body's master metabolic
hormone.
It's like a traffic cop, right?
Rachel (02:10):
Right.
It's deciding where energygoes.
Does it get burned or does itget stored?
Mark (02:14):
Exactly.
And the problem in T2D isn'tjust high glucose, that's the
result.
The core issue is that yourtissues, your liver, your fat,
your muscles, they just stopresponding to that traffic cop
in a coordinated way.
Rachel (02:26):
And what the research really clarifies is that this
resistance, it's not some simpleon or off switch.
Mark (02:31):
So it's not all or nothing.
Rachel (02:33):
Not at all.
If all insulin action juststopped, you'd be in absolute
metabolic distress immediately.
Instead, T2D is characterizedby what we call uh partial or
selective insulin resistance.
Meaning that when insulinissues a command, some cells
hear it loud and clear, somehear it faintly, and well, some
seem to ignore one command whilestill following another
(02:55):
perfectly.
Mark (02:55):
And that unevenness.
Rachel (02:56):
Yeah.
Mark (02:57):
That's the root of the chaos.
Rachel (02:58):
That's it.
Mark (02:59):
So this brings us to what you call the central paradox.
And this happens in the liver.
So normally you eat insulinspikes and it sends two
immediate, really criticalmessages to your liver.
What are they?
Rachel (03:11):
Okay.
So first, insulin tells theliver stop producing new
glucose.
That process is called uhgluconeogenesis.
Mark (03:18):
Making new sugar.
Rachel (03:19):
Literally.
And second, insulin tells theliver, okay, we have extra fuel,
store it safely, and you know,turn some of that extra energy
into fat if you need to.
That's lipogenesis.
Mark (03:29):
Aaron Powell So in this state of selective resistance,
what happens to those twocommands?
Rachel (03:33):
This is where that communication breakdown becomes
so destructive.
The liver, it basically goesdeaf to that first vital
message.
Mark (03:41):
The one to stop making glucose.
Rachel (03:42):
That signal is lost.
So even when your blood sugaris already high from a meal, the
liver just keeps churning outmore glucose.
Mark (03:50):
It's like an overflowing sink and the tap won't turn off.
Rachel (03:52):
Aaron Powell It's a perfect analogy.
And that's precisely why we seethose elevated fasting glucose
levels.
Mark (03:57):
Okay.
Meanwhile, what happens to thatsecond command, the one to
store fuel and make fat?
Rachel (04:02):
The material really emphasizes this.
That signaling pathway oftenremains robustly intact.
Oh wow.
So now the liver is in thisimpossible situation where it is
simultaneously producing waytoo much glucose.
And too much fat at the sametime.
This dual overproduction isdeeply damaging.
It leads to fat accumulatingright in the liver itself, what
(04:23):
we call fatty liver disease, orNAFLD, which then just
dramatically worsens overallinsulin resistance.
Mark (04:29):
It's a vicious cycle.
Rachel (04:30):
It's the signature cycle of metabolic syndrome and T2D.
Mark (04:34):
Okay, so let's shift gears.
We tend to think of fat tissueadipose tissue as, I don't know,
just a passive sac where westore energy.
Rachel (04:41):
Right.
Mark (04:42):
But our deep dive suggests that fat is an incredibly
active metabolic organ.
It's not just where resistanceis stored, it's one of the main
drivers making the problem worseeverywhere else.
Rachel (04:53):
Absolutely.
Think of your fat tissue,especially the uh visceral or
abdominal fat as a reservoirthat's under pressure.
When those fat cells becomedysfunctional because of insulin
resistance, they stopregulating storage properly.
Mark (05:06):
Okay.
Rachel (05:07):
So instead of keeping fatty acids locked away, they
start releasing excessiveamounts of free fatty acids or F
FFA into the bloodstream.
We call this fatty acidspillover.
Mark (05:17):
And why is that spillover so bad?
What do these free fatty acidsdo?
Rachel (05:20):
They're essentially metabolic toxins once they're
out in the open like that.
They travel directly to otherorgans like the liver and the
muscle, and they activelyinterfere with insulin's ability
to signal properly.
Mark (05:32):
So they're spreading the resistance.
Rachel (05:33):
Exactly.
They promote furtherresistance, making glucose
control dramatically worse.
The fat tissue is no longerjust sitting there, it's
aggressively undermining thebody's entire fuel handling
system.
Mark (05:44):
Creating a powerful, reinforcing feedback loop.
Rachel (05:48):
A loop that locks the body into a state of disease.
Mark (05:51):
So the body is fighting this war on two fronts.
The liver is overproducingglucose, and now dysfunctional
fat is flooding the system withthese resistance-inducing fatty
acids.
That brings us to the muscles.
What's their role?
Rachel (06:05):
Muscle tissue is the body's largest potential glucose
consumer.
It's a huge sink for glucose.
Mark (06:10):
So after a meal, it should be soaking it all up.
Rachel (06:12):
It should be sponging up a huge amount of that glucose
to replenish its energy stores.
But in T2D, the muscle becomes,well, lazy.
It's less responsive toinsulin.
Which means Which means glucoseclearance is slow, and that
prolongs that post-meal spike ofglucose in your bloodstream.
Mark (06:29):
And when the muscle isn't clearing the glucose and the
liver keeps making it, who picksup the slack?
We often assume T2D means thepancreas has just failed, but
that's not what happens earlyon, is it?
Rachel (06:39):
No, it's actually the opposite.
Early T2D is usually not aboutinsulin deficiency.
The pancreas, it compensatesfor all this resistance by
working overtime.
It pumps out vastly moreinsulin, sometimes four or five
times the normal amount.
Right.
The core problem is that thebody just requires too much
insulin to function because thetissues are so resistant.
Mark (07:01):
So the pancreas is being asked to run a marathon every
single day.
Rachel (07:04):
Every single day.
And it's this constant highdemand, this overwork that puts
chronic crippling stress on theinsulin-producing beta cells.
Mark (07:12):
Not a sudden thing.
Rachel (07:13):
It's not a sudden failure.
It's a gradual functionalexhaustion over many, many years
that eventually leads to thedecline of those crucial cells.
Mark (07:21):
Okay, so if T2D is this deep metabolic problem, this
chaotic interaction, thenachieving remission has to
require deep physiologicalchanges.
Rachel (07:30):
Mm-hmm.
Mark (07:30):
Better blood glucose is just the consequence of these
deeper changes, not the maingoal itself.
And the material points to fourthings that have to improve
together.
Rachel (07:39):
That's right.
And the first two points goright back to calming the chaos
we just talked about.
Point one is restoring liversensitivity.
The liver has to regain itsability to listen to insulin's
signal to, you know, cut back onglucose output.
Mark (07:53):
Aaron Powell And that's tied to liver fat.
Rachel (07:55):
It is directly linked to reductions in liver fat.
And the research suggests thatlosing liver fat is often more
important for remission thanoverall weight loss alone.
You reduce liver fat, youquickly see lower fasting
glucose.
Mark (08:07):
And then we had to deal with that fuel spillover.
So point two is restoringadipose tissue sensitivity.
Trevor Burrus, Jr.
Rachel (08:13):
That's critical.
The fat cells need to becomesensitive again so that insulin
can effectively suppress thatunnecessary fat breakdown, what
we call the anti-lipolyticsignal.
Mark (08:22):
And when that happens.
Rachel (08:23):
The dangerous fatty acid spillover to the liver and
muscle slows right down, whichallows those other organs to
finally function better.
Mark (08:30):
Aaron Powell And then moving on, we had to get our
main fuel consumer back in thegame.
Point three is muscle recovery.
Rachel (08:35):
Yep.
We need that muscle tissue tobecome sensitive again to clear
glucose efficiently after mealsand stabilize those postmeal
levels.
Mark (08:43):
Aaron Powell Physical activity helps with that,
obviously.
Rachel (08:45):
Aaron Powell Enormously.
Mark (08:46):
Yeah.
Rachel (08:46):
But the sources are clear that dietary factors that
reduce the glucose overload inthe first place are just as
important.
Mark (08:53):
Which leads us perfectly to the ultimate goal.
Point four, lowering insulindemand.
Rachel (08:58):
That's the end game.
The objective is todramatically reduce the sheer
quantity of insulin the bodyneeds just to get through the
day.
Mark (09:05):
And when that demand falls.
Rachel (09:07):
That exhausted pancreas finally gets a chance to rest
and recover, which helpspreserve its function for the
long term.
Remiss is really that momentwhen the whole system is working
efficiently again at a muchlower level of stress.
Mark (09:20):
Right.
Let's get practical.
Let's talk strategies.
If the main goal is loweringinsulin demand and easing all
this metabolic pressure, thereason why reducing dietary
carbs is so central becomesreally clear.
Rachel (09:32):
It does.
Mark (09:33):
It's not just about avoiding sugar.
It's a whole metabolicrestructuring.
Rachel (09:37):
Think about the resistance system as a factory
that's already running at maxcapacity.
Carbohydrates are the mainnutrient that raises blood
glucose and therefore triggersthat immediate, urgent release
of insulin.
Mark (09:49):
So if you're already resistant.
Rachel (09:50):
A high carbohydrate intake means you're just
constantly forcing your pancreasto pump out more and more
insulin just to keep your bloodsugar from going haywire.
Mark (09:58):
So how exactly does reducing that glucose input help
the pancreas?
Is it just less work or isthere more to it?
Rachel (10:05):
It's both.
Less glucose coming in meansblood sugar rises less after
meals, so you need less insulinoverall.
This stabilization reduces thatchronic high level of insulin,
which is anti-inflammatory, andlets the pancreas rest.
Mark (10:20):
And the liver?
Rachel (10:21):
Oh, the liver is highly sensitive to the amount of
glucose coming in.
Lower card input decreases theliver's tendency to overproduce
glucose, it helps it shed thatliver fat faster, and it
improves the liver's overallresponse to insulin.
It tackles that paradox headon.
Mark (10:36):
Now, medication, like metformin, often comes into the
picture early, and the materialsuggests we should see it not as
a defeat, but as a a temporarytool.
Rachel (10:46):
The support tool.
That's the key mindset shift.
Metformin primarily works onthe liver to reduce that
excessive glucose production.
It basically puts a speed limiton that broken tap.
Mark (10:55):
So it lowers the burden.
Rachel (10:56):
Exactly.
It lowers the overall metabolicburden, it gives the system a
critical break, and it allowsthe recovery process from diet
and lifestyle to just happenfaster.
Mark (11:05):
The sources do make a strong point about treatment,
though.
If the core problem isresistance, we have to question
the traditional approach of justadding more and more insulin.
Rachel (11:15):
That is a crucial area for you to consider.
T2D is resistance.
And while insulin is, ofcourse, necessary for type 1
diabetes, using ever-escalatingdoses of insulin in a T2D
patient who hasn't fullycontrolled their glucose load
can be counterproductive.
Mark (11:33):
How so?
Rachel (11:34):
Well, high insulin levels can sometimes reinforce
the resistance, creating areally toxic feedback loop.
The need for more and moreinjected insulin should always
be a signal that something isfundamentally unaddressed.
Trevor Burrus, Jr.
Mark (11:45):
Either the diet or something else.
Trevor Burrus, Jr.
Rachel (11:47):
Or perhaps more likely unaddressed stressors.
Mark (11:50):
Aaron Powell And if the dietary input is controlled but
glucose is still stubbornlyhigh, that's when we have to
look for those underappreciatedphysiologic stressors that are
actively sabotaging insulinaction.
What are some of those?
Rachel (12:01):
Aaron Powell This is where the deeper investigation
begins.
The most common is excesscortisol, often driven by
chronic emotional stress, pain,or just poor sleep quality.
Mark (12:10):
And cortisol raises blood sugar.
Rachel (12:12):
It's a powerful counter-regulatory hormone.
When it's chronically high, itconstantly opposes insulin.
We also have to look at loss ofmuscle mass sarcopenia.
Remember, muscle is yourbiggest glucose sponge.
Right.
If you lose it, you have fewerplaces for the glucose to go,
which makes managementexponentially harder.
And finally, you look forthings like systemic
(12:33):
inflammation or hormonalimbalances.
If glucose control is tough,you have to look beyond the
plate and consider the totalphysiologic burden on your body.
Mark (12:41):
This brings us to the final and maybe most actionable
piece for you (12:44):
tracking success.
Blood glucose checks and HBA1C,they give you an incomplete
picture.
Rachel (12:51):
Very incomplete.
Mark (12:51):
They tell you what happened, but not why it
happened or where the breakdownis.
You need better information.
Rachel (12:56):
You need to measure insulin demand.
A single lab measurement offasting insulin taken alongside
your glucose reading gives youvital context.
And the distinction here reallymatters for your action plan.
Mark (13:06):
Okay, let's break down the two main scenarios.
Rachel (13:09):
Scenario one you have high fasting insulin and high
glucose.
That screams severe resistance.
Your pancreas is still tryingto keep up.
It's working hard, but it'sfailing because the demand is
overwhelming.
So the focus there has to beruthlessly on reducing that
glucose load and maximizingtissue sensitivity.
Mark (13:30):
Okay.
And scenario two, what if thepancreas has started to get
tired?
Rachel (13:35):
Well, if you have normal or even low fasting insulin and
high glucose, that raises areal concern for significant
beta cell dysfunction.
Or maybe a powerful acuteinterfering factor like severe
stress or an illness.
Mark (13:49):
And that distinction changes the whole plan.
Rachel (13:51):
Completely.
It guides the clinician onwhether to focus on resting the
pancreas or digging deeper intohormonal interference.
Mark (13:57):
So fasting insulin tells us the status of the pancreas.
What about tracking that lividchaos, the liver fat and the
overflow?
Rachel (14:03):
For that, you should always track your triglycerides
and the triglyceride to HDLratio.
Mark (14:08):
Okay.
Rachel (14:08):
Research shows these markers correlate powerfully
with that hepatic insulinresistance and the lipid
spillover from dysfunctionalfat.
Mark (14:14):
So high triglycerides, low HDL, that's a bad sign.
Rachel (14:19):
It's a strong indicator of metabolic chaos.
But these are often the veryfirst things that improve, often
before your glucose stabilizes,which shows you that the deep
changes are working.
We also look at basic liverenzymes, ALT and AST.
Even when they're in the normalrange, a slight elevation can
still suggest some fatty liverinvolvement.
Mark (14:40):
So these tests let you pinpoint which lever is still
stuck.
Is it the liver?
Is it the fat tissue?
Or is it some hidden hormonalstressor?
Rachel (14:49):
Aaron Powell Precisely.
It stops you from justescalating therapy blindly
because the HBA1C is high.
Mark (14:54):
So HBA1C is more of a lagging indicator.
Rachel (14:57):
It's a trajectory marker.
It tells you where you've beenfor the last three months.
But these other metabolicmarkers, fasting insulin,
triglycerides, the ratio, theytell you where you are going and
critically why certainstrategies are or aren't
working.
Mark (15:08):
Aaron Powell So let's bring it all together.
The core takeaway from thisdeep dive is that T2D is not a
sentence of permanent metabolicdecline.
Rachel (15:15):
Not at all.
Mark (15:15):
It's highly modifiable, especially in the early stages.
And remission is achieved byrestoring that metabolic
balance.
Rachel (15:21):
It's about reducing glucose input, dramatically
improving sensitivity acrossyour liver, muscle, and fat
tissues, and successfullylowering the demand placed on
your pancreas.
Mark (15:32):
A total system reset.
Rachel (15:33):
Exactly.
And here is the final thoughtfor you to carry forward.
If you are doing everythingright, you have sincerely
addressed your diet, you'reconsistent, and yet your blood
glucose is proving stubbornlyhard to control, what
unaddressed hormonal orinflammatory stressor could be
powerfully opposing insulinaction right now.
Mark (15:50):
Is it sleep?
Is it stress?
Rachel (15:53):
Is it chronic cortisol?
Identifying that hidden force,that's where the deeper
investigation and your bestchance at lasting remission
truly begins.
Mark (16:01):
Thank you for joining us for this deep dive into decoding
the metabolic paradox.
Nicolette (16:05):
We hope this knowledge empowers you to ask
better questions and achievebetter
results.quicklabmobile.com.
(16:27):
Stay informed, stay healthy,and we'll catch you in the next
episode.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Betrayal Season 5
Saskia Inwood woke up one morning, knowing her life would never be the same. The night before, she learned the unimaginable – that the husband she knew in the light of day was a different person after dark. This season unpacks Saskia’s discovery of her husband’s secret life and her fight to bring him to justice. Along the way, we expose a crime that is just coming to light. This is also a story about the myth of the “perfect victim:” who gets believed, who gets doubted, and why. We follow Saskia as she works to reclaim her body, her voice, and her life. If you would like to reach out to the Betrayal Team, email us at betrayalpod@gmail.com. Follow us on Instagram @betrayalpod and @glasspodcasts. Please join our Substack for additional exclusive content, curated book recommendations, and community discussions. Sign up FREE by clicking this link Beyond Betrayal Substack. Join our community dedicated to truth, resilience, and healing. Your voice matters! Be a part of our Betrayal journey on Substack.